Arcutis Biotherapeutics, Inc. (ARQT) KPIs and segments
Close on Nov 17, 2026Market cap $3.44BP/E 124.2Yield –
KPIs & segments
Operating metrics and segments that drive Arcutis Biotherapeutics's business
Arcutis Biotherapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZORYVE foam($M) | 67.4 | 49.6 | 62.7 | 49.8 | 39.2 | 30.2 | 31.1 | 20.3 | 13.6 | 6.54 | 0 | 0 | |
ZORYVE cream 0.3%($M) | 35.3 | 32.7 | 39.4 | 30.5 | 27.7 | 23.4 | 30.8 | 22.0 | 17.3 | 15.0 | 13.5 | 8.11 | |
ZORYVE cream 0.15%($M) | 24.2 | 21.7 | 24.5 | 18.9 | 14.6 | 10.2 | 7.47 | 2.45 | 0 | 0 | 0 | 0 | |
ZORYVE cream 0.05%($M) | 2.93 | 1.36 | 0 | 0 | |||||||||
Earlier reporting (last reported 2023)2 | |||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?